The companies were the latest to agree to sell drugs to Medicaid and directly to consumers at discounted prices. President ...

The deal announced Friday tacks on to similar reduced price agreements the Trump administration has made with five other ...

U.S. President Donald Trump announced Friday that nine drugmakers have agreed to lower the cost of their prescription drugs ...

Pharma companies have agreed to lower prices and invest in the U.S. in exchange for avoiding tariffs and benefits like faster ...

Amgen AMGN recently signed a landmark agreement with the Trump administration to lower drug prices in the United States. Through this deal, Amgen addresses the two major concerns that have plagued Big ...

They agreed to charge the U.S. government no more for new drugs than the prices paid by other well-off countries. The agreements will allow state Medicaid programs to access lower prices from the nine ...

Swiss pharma giants Novartis and Roche on Thursday backed U.S. efforts to lower the cost of drugs and are working with the ...

Eli Lilly and Novo Nordisk will lower prices for GLP-1 receptor agonists, aligning with the Most Favored Nation executive order to address US drug pricing disparities. Novo Nordisk's semaglutide ...

In the closing months of 2025, President Donald Trump’s effort to reshape how Americans pay for prescription drugs has taken clearer form. What started as a campaign threat to slap tariffs on ...

The United States and the United Kingdom reached an agreement in principle on pharmaceutical pricing. The update comes as part of the U.S.–U.K. Economic Prosperity Deal (EPD), announced Dec. 1. The ...

The U.S. and the United Kingdom reached an agreement in principle to address pharmaceutical pricing disparities and secure investment under the U.S.-U.K. Economic Prosperity Deal. According to a Dec.